Fatigue: Biomedicine, Health & Behavior - Volume 2, Issue 2, 2014

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search

Titles and abstracts for the journal, Fatigue: Biomedicine, Health & Behavior, Volume 2, Issue 2, 2014.

Volume 2, Issue 2, 2014[edit | edit source]

  • The delayed fatigue effect in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
    Abstract - Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating, long-term condition characterised by extreme fatigue (worsened by exertion), muscle and joint pain, and sleep disturbance. Post-exertional fatigue has been demonstrated previously following physical exercise, but not from mental exertion alone. Purpose: The aim of this exploratory study was to assess the ‘delayed fatigue effect,’ in this instance fatigue two days post-challenge, following a cognitively fatiguing task. Methods: Thirty-two participants (23 women; mean age 44, SD = 11.24; mean illness duration nine years, SD = 7.32) completed the Cambridge Neuropsychological Test Automated Battery, which acted as the cognitive challenge. Self-report measures were also completed that assessed fatigue (Multidimensional Fatigue Inventory; MFI), and anxiety and depression (Hospital Anxiety and Depression Scale; HADS) pre- and two days post-testing. Results: Significant differences were found between pre- and post-test measures in three MFI sub-scales of fatigue (general, mental, and physical) and on the depression scale of the HADS. However, there were no significant changes in motivation, activity level, or self-reported anxiety scores. Conclusions: These findings are suggestive of post-exertional symptom exacerbation following mental effort. This may have implications for working environments that present cognitive demands to individuals with ME/CFS."[1]
  • Fatigue and body mass index in the Fragile X premutation carrier
    Abstract - Background: Recent evidence has shown that mitochondrial dysfunction may be significant in carriers of the Fragile X premutation. Purpose: The present study examined fatigue severity and body mass index (BMI) (two possible outcomes related to mitochondrial dysfunction) in premutation carriers with and without the Fragile X-associated Tremor Ataxia Syndrome (FXTAS) as compared to controls. Methods: Surveys to gather data on height and weight and fatigue impact (Fatigue Severity Scale) were sent out to previous research trial participants with Fragile X premutation-related disorders. Results: On the Fatigue Severity Scale, carriers with and without FXTAS had mean scores of 4.5 (SD 1.9) and 3.8 (SD 1.6), respectively, that differed significantly (p < 0.001) from the control mean score of 2.9 (SD 1.4). The mean BMI of carriers with FXTAS was 29.6 kg/m2 (SD 5.3) which differed significantly (p = 0.003) from the mean BMI of carriers without FXTAS of 26.9 kg/m2 (SD 5.1) and controls 26.7 kg/m2 (SD 4.4). However, premutation carriers without FXTAS did not differ significantly in BMI from controls. Conclusions: The present study suggests potentially important clinical outcomes that may be related to the mitochondrial dysfunction seen in molecular studies previously done with premutation carriers.[2]
  • Acute and chronic hypoxia: implications for cerebral function and exercise tolerance.
    Abstract - Purpose: To outline how hypoxia profoundly affects neuronal functionality and thus compromises exercise performance. Methods: Investigations were reviewed and evaluated that used electroencephalography (EEG) and transcranial magnetic stimulation (TMS) to detect neuronal changes at rest and those studying fatiguing effects on whole-body exercise performance in acute (AH) and chronic hypoxia (CH). Results: At rest during very early hypoxia (<1-h), slowing of cerebral neuronal activity is evident despite no change in corticospinal excitability. As time in hypoxia progresses (3-h), increased corticospinal excitability becomes evident; however, changes in neuronal activity are unknown. Prolonged exposure (3–5 d) causes a respiratory alkalosis which modulates Na+ channels, potentially explaining reduced neuronal excitability. Locomotor exercise in AH exacerbates the development of peripheral fatigue; as the severity of hypoxia increases, mechanisms of peripheral fatigue become less dominant and CNS hypoxia becomes the predominant factor. The greatest central fatigue in AH occurs when SaO2 is ≤75%, a level that coincides with increasing impairments in neuronal activity. CH does not improve the level of peripheral fatigue observed in AH; however, it attenuates the development of central fatigue paralleling increases in cerebral O2 availability and corticospinal excitability. Conclusions: The attenuated development of central fatigue in CH might explain the improvements in locomotor exercise performance commonly observed after acclimatisation to high altitude.[3]
  • Chronic Fatigue Syndrome: The Current Status and Future Potentials of Emerging Biomarkers (FULL TEXT)
    Abstract - Chronic fatigue syndrome (CFS) remains an incompletely characterized illness, in part due to controversy regarding its definition, biological basis and diagnosis. Biomarkers are objective measures that may lead to improvements in our understanding of CFS by providing a more coherent and consistent approach to study, diagnosis and treatment of the illness. Such metrics may allow us to distinguish between CFS subtypes – each defined by characteristic biomarkers – currently conflated under the single, heterogeneous condition of CFS. These delineations, in turn, may guide more granular, focused, and targeted treatment strategies based on more precise characterizations of the illness. Here, we review potential CFS biomarkers related to neurological and immunological components of the illness, and discuss how these biomarkers may be used to move the field of CFS forward, emphasizing clinical utility and potential routes of future research. [4]
  • Feasibility of a home-based self-management program for chronic fatigue
    Abstract - Purpose: This study evaluated the feasibility of a 12-week home-based self-management program for unexplained chronic fatigue (UCF) or chronic fatigue syndrome (CFS). Methods: Self-report outcomes included measures of fatigue impact, physical function, depression, and global change. A web diary measured daily compliance with self-management activities. Results: Study withdrawals (20.8%) were due to time constraints, confidentiality concerns, or illness recovery. Subjects (N = 19) showed excellent compliance (62.3%) on the web diary. Participant feedback indicated high satisfaction. Effect sizes were large for fatigue severity, physical functioning, and depression. Conclusions: A home-based self-management program for UCF and CFS may offer improved patient access to treatment that may be unavailable, inconvenient, or costly. [5]

See also[edit | edit source]

References[edit | edit source]

  1. Arroll, M. A.; Attree, E. A.; O'Leary, J. M.; Dancey, C. P. (2014), "The delayed fatigue effect in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)", Fatigue: Biomedicine, Health & Behavior, 2 (2): 57-63, doi:10.1080/21641846.2014.892755 
  2. Summers, S. M., Cogswell, J., Goodrich, J. E., Mu, Y., Nguyen, D. V., Brass, S. D., & Hagerman, R. J. (2014). Fatigue and body mass index in the Fragile X premutation carrier. Fatigue: Biomedicine, Health & Behavior, 2 (2), 64-72. doi:10.1080/21641846.2014.881155
  3. Goodall, S., Twomey, R., & Amann, M. (2014). Acute and chronic hypoxia: implications for cerebral function and exercise tolerance. Fatigue: biomedicine, health & behavior, 2(2), 73-92. doi:10.1080/21641846.2014.909963
  4. Fischer, David B.; William, Arsani H.; Strauss, Adam C.; Unger, Elizabeth R.; Jason, Leonard; Marshall, Jr, Gailen D.; Dimitrakoff, Jordan D. (2014), "Chronic Fatigue Syndrome: The Current Status and Future Potentials of Emerging Biomarkers", Fatigue: Biomedicine, Health & Behavior, 2 (2): 93-109, doi:10.1080/21641846.2014.906066 
  5. Fred Friedberg, Ngan, M. C., & Chang, J. (2014). Feasibility of a home-based self-management program for chronic fatigue. Fatigue: Biomedicine, Health & Behavior, 2 (2), 110-118. doi:10.1080/21641846.2014.904066

ME/CFS - An acronym that combines myalgic encephalomyelitis with chronic fatigue syndrome. Sometimes they are combined because people have trouble distinguishing one from the other. Sometimes they are combined because people see them as synonyms of each other.

mitochondria - Important parts of the biological cell, with each mitochondrion encased within a mitochondrial membrane. Mitochondria are best known for their role in energy production, earning them the nickname "the powerhouse of the cell". Mitochondria also participate in the detection of threats and the response to these threats. One of the responses to threats orchestrated by mitochondria is apoptosis, a cell suicide program used by cells when the threat can not be eliminated.

central nervous system (CNS) - One of the two parts of the human nervous system, the other part being the peripheral nervous system. The central nervous system consists of the brain and spinal cord, while the peripheral nervous system consists of nerves that travel from the central nervous system into the various organs and tissues of the body.

chronic fatigue syndrome (CFS) - A fatigue-based illness. The term CFS was invented invented by the U.S. Centers for Disease Control as an replacement for myalgic encephalomyelitis (ME). Some view CFS as a neurological disease, others use the term for any unexplained long-term fatigue. Sometimes used as a the term as a synonym of myalgic encephalomyelitis, despite the different diagnostic criteria.

myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

chronic fatigue syndrome (CFS) - A fatigue-based illness. The term CFS was invented invented by the U.S. Centers for Disease Control as an replacement for myalgic encephalomyelitis (ME). Some view CFS as a neurological disease, others use the term for any unexplained long-term fatigue. Sometimes used as a the term as a synonym of myalgic encephalomyelitis, despite the different diagnostic criteria.

chronic fatigue (CF) - Persistent and abnormal fatigue is a symptom, not an illness. It may be caused by depression, multiple sclerosis, fibromyalgia, chronic fatigue syndrome or many other illnesses. The term "chronic fatigue" should never be confused with the disease chronic fatigue syndrome.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.